Volunteers Needed for Novavax Vaccine Trial at Womack Army Medical Center

Volunteers Needed for Novavax Vaccine Trial at Womack Army Medical Center

Military and connected beneficiaries of Fort Bragg’s Military Health System and Tricare can lend a hand to help the biomedical research necessary to get another COVID-19 vaccine to market. Phase 3 clinical trials for the experimental vaccine produced by Novavax are open at Womack Army Medical Center. Health officials are looking for volunteers to take part. Although a couple vaccines have already been authorized for emergency use by the U.S. Food and Drug Administration (FDA) additional vaccines are necessary. Already the vaccine rollouts are hampered by a number of factors including production challenges, at least in Belgium in association with the Pfizer/BioNTech product. The work of research is very much in demand and participant contribution makes the effort successful or not.

Additional Vaccine Option

The Novavax vaccine differs from the ones made by Pfizer and Moderna, both of which began rolling out to the public in December. Those vaccines use a new method, a synthetic mRNA (messenger RNA), which triggers antibodies that protect against the COVID-19 virus.

The Novavax vaccine is similar to past vaccines. It is made partly from a protein that spurs an antibody response. “It’s a more traditional vaccine,” McClenathan says. “It’s very similar to something like the shingles vaccine.” 

The vaccine, produced by a Maryland-based company, could receive emergency authorization in April and be delivered to the federal government by the end of June, according to The New York Times. 

Lead Investigator

Bruce M. McClenathan, MD

About the Research Site

The Military Health System (MHS) is one of America’s largest and most complex health care institutions, and the world’s preeminent military health care delivery operation. Our MHS saves lives on the battlefield, combats infectious disease around the world, and cares for 9.5 million beneficiaries in one of the nation’s largest health benefit plans.

The missions of the MHS are complex and interrelated:

  • To ensure America’s 1.4 million active duty and 331,000 reserve-component personnel are healthy so they can complete their national security missions.
  • To ensure that all active and reserve medical personnel in uniform are trained and ready to provide medical care in support of operational forces around the world.
  • To provide a medical benefit commensurate with the service and sacrifice of more than 9.5 million active duty personnel, military retirees and their families.


Call to Action: Interested in the trial? Email [email protected] or call 253-316-3436; 253-316-3437; or 253-316-3438.

Responses

  1. It’s completely unethical to run placebo controlled vaccine trials now that there are multiple vaccines available that show strong efficacy. No wonder they are finding it difficult to fully enroll. They and every other future vaccine candidate should be required to design their trials to show clinical equivalence against the vaccines that have already received EUAs.